Skip to main content

Advertisement

SpringerLink
Log in

Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome

  • Research Article
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

We integrated LC-MS/MS-based and protein antibody array-based proteomics with genomics approaches to investigate the phosphoproteome and transcriptome of gastric cancer cell lines and endoscopic gastric biopsies from normal subjects and patients with benign gastritis or gastric cancer. More than 3,000 non-redundant phosphorylation sites in over 1,200 proteins were identified in gastric cancer cells. We correlated phosphoproteome data with transcriptome data sets and reported the expression of 41 protein kinases, 5 phosphatases and 65 phosphorylated mitochondrial proteins in gastric cancer cells. Transcriptional expression levels of 190 phosphorylated proteins were >2-fold higher in gastric cancer cells compared to normal stomach tissue. Pathway analysis demonstrated over-presentation of DNA damage response pathway and underscored critical roles of phosphorylated p53 in gastric cancer. This is the first study to comprehensively report the gastric cancer phosphoproteome. Integrative analysis of the phosphoproteome and transcriptome provided an expansive view of molecular signaling pathways in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

RTK:

Receptor tyrosine kinase

MS:

Mass spectrometry

HPLC:

High-performance liquid chromatography

FDR:

False discovery rate

ERLIC:

Electrostatic repulsion-hydrophilic interaction chromatography

SCX:

Strong cation exchange

IMAC:

Immobilized metal ion affinity chromatography

DDR:

DNA damage response

References

  1. Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2:28–37

    Article  PubMed  CAS  Google Scholar 

  2. Wagner AD, Moehler M (2009) Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era. Curr Opin Oncol 21:381–385

    Article  PubMed  CAS  Google Scholar 

  3. Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297

    Article  PubMed  CAS  Google Scholar 

  4. Di Cosimo S, Baselga J (2010) Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]. Nat Rev Clin Oncol 7:139–147

    Article  PubMed  Google Scholar 

  5. Esteva FJ, Yu D, Hung MC, Hortobagyi GN (2010) Molecular predictors of response to trastuzumab and lapatinib in breast cancer. Nat Rev Clin Oncol 7:98–107

    Article  PubMed  CAS  Google Scholar 

  6. Daub H, Specht K, Ullrich A (2004) Strategies to overcome resistance to targeted protein kinase inhibitors. Nat Rev Drug Discov 3:1001–1010

    Article  PubMed  CAS  Google Scholar 

  7. Xu AM, Huang PH (2010) Receptor tyrosine kinase coactivation networks in cancer. Cancer Res 70:3857–3860

    Article  PubMed  CAS  Google Scholar 

  8. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316:1039–1043

    Article  PubMed  CAS  Google Scholar 

  9. Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ (2006) Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol 3:269–280

    Article  PubMed  CAS  Google Scholar 

  10. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, Chin L, DePinho RA (2007) Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318:287–290

    Article  PubMed  CAS  Google Scholar 

  11. Cutsem EV, Kang Y, Chung H, Shen L, Sawaki A, Lordick F, Hill J, Lehle M, Feyereislova A, Bang Y (2009) Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC). J Clin Oncol 27:18s Suppl. abstr LBA4509

    Article  Google Scholar 

  12. Dragovich T, Campen C (2009) Anti-EGFR-targeted therapy for esophageal and gastric cancers: an evolving concept. J Oncol 2009:804108

    PubMed  Google Scholar 

  13. Iwasaki J, Nihira S (2009) Anti-angiogenic therapy against gastrointestinal tract cancers. Jpn J Clin Oncol 39:543–551

    Article  PubMed  Google Scholar 

  14. Comoglio PM, Giordano S, Trusolino L (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7:504–516

    Article  PubMed  CAS  Google Scholar 

  15. Arkenau HT (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol 135:855–866

    Article  PubMed  Google Scholar 

  16. Grabsch H, Sivakumar S, Gray S, Gabbert HE, Muller W (2010) HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value—conclusions from 924 cases of two independent series. Cell Oncol 32:57–65

    PubMed  Google Scholar 

  17. Huang PH, White FM (2008) Phosphoproteomics: unraveling the signaling web. Mol Cell 31:777–781

    Article  PubMed  CAS  Google Scholar 

  18. Macek B, Mann M, Olsen JV (2009) Global and site-specific quantitative phosphoproteomics: principles and applications. Annu Rev Pharmacol Toxicol 49:199–221

    Article  PubMed  CAS  Google Scholar 

  19. Diella F, Gould CM, Chica C, Via A, Gibson TJ (2008) Phospho.ELM: a database of phosphorylation sites—update 2008. Nucleic Acids Res 36:D240–D244

    Article  PubMed  CAS  Google Scholar 

  20. Diella F, Cameron S, Gemund C, Linding R, Via A, Kuster B, Sicheritz-Ponten T, Blom N, Gibson TJ (2004) Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 5:79

    Article  PubMed  Google Scholar 

  21. http://www.phosphosite.org

  22. Bodenmiller B, Campbell D, Gerrits B, Lam H, Jovanovic M, Picotti P, Schlapbach R, Aebersold R (2008) PhosphoPep—a database of protein phosphorylation sites in model organisms. Nat Biotechnol 26:1339–1340

    Article  PubMed  CAS  Google Scholar 

  23. Gnad F, Ren S, Cox J, Olsen JV, Macek B, Oroshi M, Mann M (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol 8:R250

    Article  PubMed  Google Scholar 

  24. Knight ZA, Lin H, Shokat KM (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10:130–137

    Article  PubMed  CAS  Google Scholar 

  25. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7:833–846

    Article  PubMed  CAS  Google Scholar 

  26. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117:699–711

    Article  PubMed  CAS  Google Scholar 

  27. Vintonyak VV, Antonchick AP, Rauh D, Waldmann H (2009) The therapeutic potential of phosphatase inhibitors. Curr Opin Chem Biol 13:272–283

    Article  PubMed  CAS  Google Scholar 

  28. Gan CS, Guo T, Zhang H, Lim SK, Sze SK (2008) A comparative study of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus SCX-IMAC-based methods for phosphopeptide isolation/enrichment. J Proteome Res 7:4869–4877

    Article  PubMed  CAS  Google Scholar 

  29. Guo T, Gan CS, Zhang H, Zhu Y, Kon OL, Sze SK (2008) Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation. J Proteome Res 7:4831–4840

    Article  PubMed  CAS  Google Scholar 

  30. Zhu Y, Guo T, Park JE, Li X, Meng W, Datta A, Bern M, Lim SK, Sze SK (2009) Elucidating in vivo structural dynamics in integral membrane protein by hydroxyl radical footprinting. Mol Cell Proteomics 8:1999–2010

    Article  PubMed  CAS  Google Scholar 

  31. Fenyo D, Beavis RC (2003) A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes. Anal Chem 75:768–774

    Article  PubMed  Google Scholar 

  32. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang X, Shi W, Bryant SH (2004) Open mass spectrometry search algorithm. J Proteome Res 3:958–964

    Article  PubMed  CAS  Google Scholar 

  33. Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31:3635–3641

    Article  PubMed  CAS  Google Scholar 

  34. Bodenmiller B, Mueller LN, Mueller M, Domon B, Aebersold R (2007) Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat Methods 4:231–237

    Article  PubMed  CAS  Google Scholar 

  35. Alpert AJ (2008) Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. Anal Chem 80:62–76

    Article  PubMed  CAS  Google Scholar 

  36. Alves G, Wu WW, Wang G, Shen RF, Yu YK (2008) Enhancing peptide identification confidence by combining search methods. J Proteome Res 7:3102–3113

    Article  PubMed  CAS  Google Scholar 

  37. Zhang H, Guo T, Li X, Datta A, Park JE, Yang J, Lim SK, Tam JP, Sze SK (2010) Simultaneous characterization of glyco- and phospho-proteomes of mouse brain membrane proteome with electrostatic repulsion hydrophilic interaction chromatography (ERLIC). Mol Cell Proteomics 9:635–647

    Article  PubMed  CAS  Google Scholar 

  38. Sarg B, Helliger W, Talasz H, Forg B, Lindner HH (2006) Histone H1 phosphorylation occurs site-specifically during interphase and mitosis: identification of a novel phosphorylation site on histone H1. J Biol Chem 281:6573–6580

    Article  PubMed  CAS  Google Scholar 

  39. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP (2006) A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 24:1285–1292

    Article  PubMed  CAS  Google Scholar 

  40. Schwartz D, Gygi SP (2005) An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 23:1391–1398

    Article  PubMed  CAS  Google Scholar 

  41. Amanchy R, Periaswamy B, Mathivanan S, Reddy R, Tattikota SG, Pandey A (2007) A curated compendium of phosphorylation motifs. Nat Biotechnol 25:285–286

    Article  PubMed  CAS  Google Scholar 

  42. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963–968

    Article  PubMed  CAS  Google Scholar 

  43. Subramanian H, Roy HK, Pradhan P, Goldberg MJ, Muldoon J, Brand RE, Sturgis C, Hensing T, Ray D, Bogojevic A, Mohammed J, Chang JS, Backman V (2009) Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res 69:5357–5363

    Article  PubMed  CAS  Google Scholar 

  44. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E (1993) Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 55:72–75

    Article  PubMed  CAS  Google Scholar 

  45. Heideman DA, Snijders PJ, Bloemena E, Meijer CJ, Offerhaus GJ, Meuwissen SG, Gerritsen WR, Craanen ME (2001) Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J Pathol 194:428–435

    Article  PubMed  CAS  Google Scholar 

  46. Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, Archibald H, Kim WJ, Okimoto RA, Bell DW, Sgroi DC, Christensen JG, Settleman J, Haber DA (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci USA 103:2316–2321

    Article  PubMed  CAS  Google Scholar 

  47. Nicholson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37 (Suppl 4):S9–S15

    Article  PubMed  CAS  Google Scholar 

  48. Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A (2006) Topoisomerase II alpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Hum Pathol 37:1333–1343

    Article  PubMed  CAS  Google Scholar 

  49. Tokuyasu N, Shomori K, Nishihara K, Kawaguchi H, Fujioka S, Yamaga K, Ikeguchi M, Ito H (2008) Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer 11:37–46

    Article  PubMed  CAS  Google Scholar 

  50. Yuan W, Chen Z, Wu S, Ge J, Chang S, Wang X, Chen J (2009) Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res 15:473–478

    Article  PubMed  CAS  Google Scholar 

  51. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM (2002) Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 8:987–993

    PubMed  CAS  Google Scholar 

  52. Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, Doki Y, Yoshida K, Aozasa K, Nakamura H, Monden M (2006) Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 12:117–122

    Article  PubMed  CAS  Google Scholar 

  53. Nikolova M, Guenova M, Taskov H, Dimitrova E, Staneva M (1998) Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. Leuk Res 22:39–47

    Article  PubMed  CAS  Google Scholar 

  54. Esseghir S, Reis-Filho JS, Kennedy A, James M, O’Hare MJ, Jeffery R, Poulsom R, Isacke CM (2006) Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol 210:420–430

    Article  PubMed  CAS  Google Scholar 

  55. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M (2009) Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci 100:249–254

    Article  CAS  Google Scholar 

  56. Prager GW, Poettler M, Schmidinger M, Mazal PR, Susani M, Zielinski CC, Haitel A (2009) CD98hc (SLC3A2), a novel marker in renal cell cancer. Eur J Clin Invest 39:304–310

    Article  PubMed  CAS  Google Scholar 

  57. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078

    Article  PubMed  CAS  Google Scholar 

  58. Harper JW, Elledge SJ (2007) The DNA damage response: 10 years after. Mol Cell 28:739–745

    Article  PubMed  CAS  Google Scholar 

  59. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912–1934

    Article  PubMed  CAS  Google Scholar 

  60. Thomson M (2002) Evidence of undiscovered cell regulatory mechanisms: phosphoproteins and protein kinases in mitochondria. Cell Mol Life Sci 59:213–219

    Article  PubMed  CAS  Google Scholar 

  61. Horbinski C, Chu CT (2005) Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med 38:2–11

    Article  PubMed  CAS  Google Scholar 

  62. Deng N, Zhang J, Zong C, Wang Y, Lu H, Yang P, Wang W, Young GW, Korge P, Lotz C, Doran P, Liem DA, Apweiler R, Weiss JN, Duan H, Ping P (2010) Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (In press) (doi:10.1074/mcp.M110.000117)

  63. Deng WJ, Nie S, Dai J, Wu JR, Zeng R (2010) Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics 9:100–116

    Article  PubMed  CAS  Google Scholar 

  64. Cui Z, Hou J, Chen X, Li J, Xie Z, Xue P, Cai T, Wu P, Xu T, Yang F (2010) The profile of mitochondrial proteins and their phosphorylation signaling network in INS-1 beta cells. J Proteome Res 9:2898–2908

    Article  PubMed  CAS  Google Scholar 

  65. Reinders J, Wagner K, Zahedi RP, Stojanovski D, Eyrich B, van der Laan M, Rehling P, Sickmann A, Pfanner N, Meisinger C (2007) Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase. Mol Cell Proteomics 6:1896–1906

    Article  PubMed  CAS  Google Scholar 

  66. Ito J, Taylor NL, Castleden I, Weckwerth W, Millar AH, Heazlewood JL (2009) A survey of the Arabidopsis thaliana mitochondrial phosphoproteome. Proteomics 9:4229–4240

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work is supported by the National Cancer Centre of Singapore Research Fund. This work is also supported by grants from the Ministry of Education (ARC: T206B3211 to SKS) and the Agency for Science, Technology and Research (BMRC: 07/1/22/19/531 to SKS) of Singapore.

Author information

Authors and Affiliations

  1. Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore

    Tiannan Guo, Sze Sing Lee, Wai Har Ng & Oi Lian Kon

  2. School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore

    Tiannan Guo, Yi Zhu, Chee Sian Gan & Siu Kwan Sze

  3. Center for Stem Cell Research and Application, Union Hospital, Huazhong University of Science and Technology, 430022, Wuhan, People’s Republic of China

    Jiang Zhu, Haixia Wang & Shiang Huang

Authors
  1. Tiannan Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sze Sing Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wai Har Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chee Sian Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haixia Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shiang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Siu Kwan Sze
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Oi Lian Kon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Siu Kwan Sze or Oi Lian Kon.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 378 kb)

Supplementary material 2 (XLS 2,341 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, T., Lee, S.S., Ng, W.H. et al. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome. Cell. Mol. Life Sci. 68, 1983–2002 (2011). https://doi.org/10.1007/s00018-010-0545-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-010-0545-x

Keywords

Search

Navigation